SVLSF IV, LLC

SVLSF IV, LLC has filed trades across 6 companies (mainly through SEC (Form 4)), most often in IVERIC bio, Inc., KalVista Pharmaceuticals, Inc. and Entellus Medical Inc. Between 15 September 2009 and 10 April 2019, the trades on record add up to 126 filings.

On the open market, the record shows 8 purchases worth €13.9M and 101 sales worth €290.8M. Netting one side against the other leaves €277.0M of net selling. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 2 share grants. Since January 2019: no purchases and 40 sales on the market.

The median purchase comes to €2.2M. Looking at 3 purchases old enough to measure, the stock rose over the following 90 days in 100% of cases; the median change was +19.7%. This is a record of the past, not a forecast.

On 10 April 2019 came the latest disclosure, an open-market sale for €16k in KalVista Pharmaceuticals, Inc. The latest purchase dates back some time: it was published 4,295 days ago, on 4 February 2015. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.